O’Brien Medical announced it has been granted a patent by the U.S. Patent and Trademark Office for its Electronic Tuning Fork, or ETF. The device offers a significant improvement over current methods used by doctors to detect diabetic peripheral neuropathy (DPN), a common precursor to diabetic limb loss.
The development of the ETF was made possible through a collaboration with Dr. Todd O’Brien, president and founder of O’Brien Medical, and the University of Maine.
More than five years ago, O’Brien approached UMaine’s Advanced Manufacturing Center for help developing a proof-of-concept ETF, and then worked with Bruce Segee of UMaine’s Department of Electrical and Computer Engineering to develop the beta and commercial versions of the device.
Segee calls the project a perfect example of how the university can help grow the Maine economy.
A Maine electronics manufacturer has been selected to produce the ETF, and O’Brien expects the device will be available for purchase in late 2014.
The full news release is available online.